Announcements Trials
Browse Landscape

Phase

Phase 2 10Phase 4 1Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 22Gastrointestinal 14Other solid neoplasm 10Sarcoma 7Tumor-Agnostic 6Breast 6Thoracic 5CNS 5Lymphoid 4Other hematologic neoplasm 3Plasma cell 2Myeloid 2Head & Neck 2Dermatologic 2Gynecologic 1Classical hematology 1

Conditions

Thoracic Neoplasms 1Pelvic Neoplasms 1Nervous System Neoplasms 1Neoplasms 1Head and Neck Neoplasms 1

Interventions

Paclitaxel 108Carboplatin 97pembrolizumab 64Cisplatin 63Cyclophosphamide 45Bevacizumab 35Taxes 31Gemcitabine 28liposomal doxorubicin 27Topotecan 26fludarabine 25olaparib 22Nivolumab 20Docetaxel 20Radiotherapy 18Brachytherapy 17veliparib 16Magnetic Resonance Spectroscopy 16Doxorubicin 16Biopsy 15Radiation 14niraparib 13aldesleukin 13Specimen Handling 13Platinum 13Oxaliplatin 13Filgrastim 13Albumin-Bound Paclitaxel 12atezolizumab 11Interleukin-2 11

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1 × Sunitinib × Gynecologic × Clear all
NCT00437372 2025-05-02

Phase IB Study Using Sunitinib Plus Radiation Therapy for Cancer Patients

Thomas Jefferson University

Phase 1 Completed
39 enrolled
GynecologicHead & NeckThoracic

Head and Neck Neoplasms, Neoplasms, Nervous System Neoplasms, Pelvic Neoplasms, Thoracic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡